TLX News: Telix and Isologic Sign License and Distribution Agreement for Illuccix® for Canada - 23rd Jun 2022, 9:00pm

[annb0t]

MELBOURNE, Australia, June 23, 2022 /CNW/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix's investigational prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian market. (PRNewsfoto/Telix Pharmaceuticals Limited)

...

>>> Read more: Telix and Isologic Sign License and Distribution Agreement for Illuccix® for Canada